Oct. 14 (Fri.) ,2016 11:30-13:00

Annex Hall

Simultaneous Interpretation

A Roadmap for Developing Biotech Start-ups in Japan

In this session, persons who are successfully acting as a venture capital and a corporate venture capital will discuss the development of Japanese health innovation in a global viewpoint.


Kiyoshi Kurokawa

Chairman, Health and Global Policy Institute / Adjunct Professor, National Graduate Institute for Policy Studies


Hal Morimoto

Managing Director, Astoria Consulting Group

Fumiaki Ikeno

Medventure Partners, Chief Medical Officer, Stanford University, Program Director (US) of Japan biodesign, Stanford Byers Center for Biodesign

Masahiko Honma

Founder and General Partner, Incubate Fund

Close Window